Follow
Sally Barrington
Sally Barrington
Verified email at kcl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification
BD Cheson, RI Fisher, SF Barrington, F Cavalli, LH Schwartz, E Zucca, ...
Journal of clinical oncology 32 (27), 3059, 2014
34102014
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
R Boellaard, R Delgado-Bolton, WJG Oyen, F Giammarile, K Tatsch, ...
European journal of nuclear medicine and molecular imaging 42 (2), 328-354, 2015
19692015
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...
Journal of clinical oncology 32 (27), 3048, 2014
12932014
Imaging biomarker roadmap for cancer studies
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
7412017
Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma
J Radford, T Illidge, N Counsell, B Hancock, R Pettengell, P Johnson, ...
New England Journal of Medicine 372 (17), 1598-1607, 2015
6222015
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma
P Johnson, M Federico, A Kirkwood, A Fosså, L Berkahn, A Carella, ...
N Engl J Med 374, 2419-2429, 2016
6142016
Detection of lymphoma in bone marrow by whole-body positron emission tomography
R Carr, SF Barrington, B Madan, MJ O'Doherty, CAB Saunders, ...
Blood, The Journal of the American Society of Hematology 91 (9), 3340-3346, 1998
3881998
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
SF Barrington, W Qian, EJ Somer, A Franceschetto, B Bagni, E Brun, ...
European journal of nuclear medicine and molecular imaging 37 (10), 1824-1833, 2010
3342010
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
BD Cheson, S Ansell, L Schwartz, LI Gordon, R Advani, HA Jacene, ...
Blood, The Journal of the American Society of Hematology 128 (21), 2489-2496, 2016
3252016
International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers
A Biggi, A Gallamini, S Chauvie, M Hutchings, L Kostakoglu, M Gregianin, ...
Journal of Nuclear Medicine 54 (5), 683-690, 2013
2992013
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ...
Haematologica 99 (6), 1107, 2014
2542014
PET scanning and the human immunodeficiency virus-positive patient
M O'Doherty, SF Barrington, M Campbell, J Lowe, CS Bradbeer
Journal of Nuclear Medicine 38 (10), 1575-1583, 1997
2521997
PET/CT for therapy response assessment in lymphoma
M Hutchings, SF Barrington
Journal of nuclear medicine 50 (Suppl 1), 21S-30S, 2009
2512009
Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam
SF Barrington, MN Maisey
Journal of Nuclear Medicine 37 (7), 1127-1129, 1996
2331996
Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography
G Morton, A Chiribiri, M Ishida, ST Hussain, A Schuster, A Indermuehle, ...
Journal of the American College of Cardiology 60 (16), 1546-1555, 2012
2282012
PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement
AB Khan, SF Barrington, NG Mikhaeel, AA Hunt, L Cameron, T Morris, ...
Blood, The Journal of the American Society of Hematology 122 (1), 61-67, 2013
2252013
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology
J Stauss, C Franzius, T Pfluger, KU Juergens, L Biassoni, J Begent, ...
European journal of nuclear medicine and molecular imaging 35 (8), 1581-1588, 2008
1882008
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
SF Barrington, R Kluge
European journal of nuclear medicine and molecular imaging 44 (1), 97-110, 2017
1852017
Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
NG Mikhaeel, D Smith, JT Dunn, M Phillips, H Møller, PA Fields, ...
European journal of nuclear medicine and molecular imaging 43 (7), 1209-1219, 2016
1812016
Early chemotherapy intensification with BEACOPP in advanced‐stage Hodgkin lymphoma patients with a interim‐PET positive after two ABVD courses
A Gallamini, C Patti, S Viviani, A Rossi, F Fiore, F Di Raimondo, ...
British journal of haematology 152 (5), 551-560, 2011
1612011
The system can't perform the operation now. Try again later.
Articles 1–20